EQUIVALENCE OF POSTOPERATIVE ANALGESIA WITH PATIENT-CONTROLLED INTRAVENOUS OR EPIDURAL ALFENTANIL

Citation
M. Chauvin et al., EQUIVALENCE OF POSTOPERATIVE ANALGESIA WITH PATIENT-CONTROLLED INTRAVENOUS OR EPIDURAL ALFENTANIL, Anesthesia and analgesia, 76(6), 1993, pp. 1251-1258
Citations number
39
Categorie Soggetti
Anesthesiology
Journal title
ISSN journal
00032999
Volume
76
Issue
6
Year of publication
1993
Pages
1251 - 1258
Database
ISI
SICI code
0003-2999(1993)76:6<1251:EOPAWP>2.0.ZU;2-B
Abstract
The analgesia and the frequency and severity of oxyhemoglobin desatura tion related to alfentanil administration were compared in 32 patients randomly selected to receive patient-controlled analgesia (PCA) by ei ther the epidural (EPI) or intravenous (IV) route for a mean period of 16 h after major abdominal surgery. Bolus increments of 250 mug of al fentanil with a lockout interval of 5 min for IV and of 1 0 min for EP I route were administered by a programmable pump. Oxygen saturation (S po2) was monitored for 16 h, using a pulse oximeter; data were collect ed continuously and stored every 30 s via an interface connected to a computer. For the purpose of analysis, Spo2 was divided into six categ ories: 95%-100%, 90%-94%, 85%-89%, 80%-84%, 75%-79%, and 70%-74%. Both routes provided similar degrees of analgesia at rest and on coughing. Maximum pain relief was obtained earlier in the IV group (P < 0.01). The total consumption of alfentanil was 13,141 +/- 3471 mug (mean +/- SD) in the IV group and 8000 +/- 4213 mug in the EPI group (p < 0.001) . The effects on Spo2 were not statistically different between the two groups. Cumulative time spent in each saturation category was similar for the EPI and IV groups. Severe desaturation episodes, defined as S po2 less-than-or-equal-to 85% for at least 60 s, occurred in 69% of pa tients in the EPI group and 56% in the IV group. The authors conclude that alfentanil EPI PCA was no more effective than IV PCA and that it was associated with the same incidence of oxyhemoglobin desaturation, emphasizing no clinical advantage to administering alfentanil by the e pidural route over the intravenous route despite the use of PCA.